全文获取类型
收费全文 | 997390篇 |
免费 | 75238篇 |
国内免费 | 2616篇 |
专业分类
耳鼻咽喉 | 12961篇 |
儿科学 | 34464篇 |
妇产科学 | 28460篇 |
基础医学 | 145275篇 |
口腔科学 | 27714篇 |
临床医学 | 90266篇 |
内科学 | 193541篇 |
皮肤病学 | 22912篇 |
神经病学 | 79106篇 |
特种医学 | 38386篇 |
外国民族医学 | 305篇 |
外科学 | 149483篇 |
综合类 | 23738篇 |
一般理论 | 385篇 |
预防医学 | 77818篇 |
眼科学 | 22608篇 |
药学 | 71860篇 |
3篇 | |
中国医学 | 2030篇 |
肿瘤学 | 53929篇 |
出版年
2018年 | 10555篇 |
2017年 | 8235篇 |
2016年 | 9373篇 |
2015年 | 10594篇 |
2014年 | 14415篇 |
2013年 | 22000篇 |
2012年 | 28981篇 |
2011年 | 30826篇 |
2010年 | 18487篇 |
2009年 | 17435篇 |
2008年 | 28786篇 |
2007年 | 30459篇 |
2006年 | 30959篇 |
2005年 | 29637篇 |
2004年 | 28924篇 |
2003年 | 27796篇 |
2002年 | 26812篇 |
2001年 | 46924篇 |
2000年 | 48033篇 |
1999年 | 40262篇 |
1998年 | 11177篇 |
1997年 | 10095篇 |
1996年 | 10160篇 |
1995年 | 9775篇 |
1994年 | 9090篇 |
1993年 | 8480篇 |
1992年 | 32248篇 |
1991年 | 31458篇 |
1990年 | 31006篇 |
1989年 | 29874篇 |
1988年 | 27167篇 |
1987年 | 27325篇 |
1986年 | 25434篇 |
1985年 | 24601篇 |
1984年 | 18397篇 |
1983年 | 15515篇 |
1982年 | 9288篇 |
1981年 | 8375篇 |
1979年 | 16859篇 |
1978年 | 12217篇 |
1977年 | 10314篇 |
1976年 | 9754篇 |
1975年 | 10178篇 |
1974年 | 12317篇 |
1973年 | 11843篇 |
1972年 | 10884篇 |
1971年 | 10115篇 |
1970年 | 9375篇 |
1969年 | 8724篇 |
1968年 | 8104篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
841.
842.
843.
Lily Shum A B M Rabie Urban H?gg 《American journal of orthodontics and dentofacial orthopedics》2004,125(2):185-190
This study assessed the amount of vascular endothelial growth factor (VEGF) expression and related the findings to new bone formation in the posterior glenoid fossa during stepwise mandibular advancement. A total of 250 female Sprague-Dawley rats, 35 days old, were randomly divided into 10 groups, each including 5 control and 20 experimental rats. Within each group, 10 experimental rats were fitted with functional appliances with a 1-step advancement of 3.5 mm. Another 10 were fitted with stepwise appliances with an initial advancement of 2 mm and a subsequent increase to 3.5 mm on day 30. The rats in the experimental groups were killed on days 3, 7, 14, 21, 30, 33, 37, 44, 51, and 60, respectively. The matched controls were killed on the same time points. Sections (7 microm) were cut through the glenoid fossa sagittally and stained with anti-VEGF antibody. VEGF expression in the posterior glenoid fossa was evaluated with a computer-assisted image-analyzing system. Both VEGF expression and new bone formation were greater in the experimental rats than in the controls. During stepwise advancement, initial VEGF expression was less than that of 1-step advancement, but the second advancement elicited another peak on day 44. New bone formation was also less than that of 1-step advancement during early stages of stepwise advancement but then began to increase from day 37 onward. The maximum increase was observed on day 60. Stepwise advancement of the mandible delivers mechanical stimuli that produce a series of tissue responses that lead to increased vascularization and bone formation. 相似文献
844.
To evaluate the long-term effects of entacapone on both mean daily 'on' time and health-related quality of life (QoL) in patients with Parkinson's disease (PD) experiencing 'end-of-dose' motor fluctuations and the benefits of an early therapeutic intervention. A prospective, multicenter, observational, 12-month study was performed with an initial 3-month intervention phase, consisting of a phone call to half of the patients from randomly selected investigators to assess if dose adjustment was necessary. Effectiveness was determined by home diaries ('on' time), subscales II and III of the Unified Parkinson's Disease Rating Scale (UPDRS), and the Parkinson's Disease Questionnaire (PDQ-8). After 3 months of treatment, 4.0% of the intervention group patients discontinued the study, versus 18.4% in the control group ( P < 0.01). The improvement in 'on' time was significantly increased since the 3-month visit (21%, P < 0.0001) until the end of the study (23% at 12 months, P < 0.0001). Entacapone also induced significant reductions in the UPDRS scores for subscales II and III and in the PDQ-8 score. 11.2% of patients experienced at least one adverse reaction. This study confirms the effectiveness of entacapone in reducing motor fluctuations by increasing 'on' time, and in improving QoL of PD patients. An early adjustment of entacapone and levodopa doses reduces the number of treatment discontinuations during the first months of treatment. 相似文献
845.
846.
847.
848.
849.
850.